What Restless Leg Syndrome Is
Restless leg syndrome - also called Willis-Ekbom disease - is a sensorimotor disorder characterized by an urge to move the legs, usually accompanied by uncomfortable sensations, that occurs at rest, is relieved by movement, and worsens in the evening or night. RLS disrupts sleep onset and sleep maintenance and is a recognized cause of chronic insomnia and daytime functional impairment.
The IRLSSG diagnostic criteria require all five of the following: an urge to move the legs usually accompanied by uncomfortable leg sensations; the urge and sensations begin or worsen during rest or inactivity; the urge and sensations are partially or totally relieved by movement; the urge and sensations are worse in the evening or night; and the symptoms are not solely accounted for as symptoms of another medical or behavioral condition.
The PTSD-RLS Link
The medical link between PTSD and RLS operates through two distinct pathways: shared neurobiology and pharmacologic side effects of PTSD treatment.
Shared Neurobiology
PTSD and RLS both involve dysregulation of dopaminergic and noradrenergic systems. PTSD is characterized by hyperactivation of the noradrenergic system and altered dopaminergic signaling in mesolimbic and nigrostriatal pathways. RLS pathophysiology centrally involves dopaminergic dysfunction in the nigrostriatal and diencephalospinal pathways, with iron homeostasis abnormalities serving as a contributing factor. Peer-reviewed literature documents elevated rates of RLS in patients with PTSD compared to age-matched controls.
Sleep Architecture Disruption
PTSD chronically disrupts sleep architecture - increased sleep latency, decreased slow-wave sleep, increased REM density, and fragmented sleep continuity. Chronic sleep disruption alters dopaminergic tone and circadian regulation, which lowers the threshold for RLS symptom expression. The result is a bidirectional relationship: PTSD-related sleep disruption worsens RLS, and RLS sleep disruption worsens PTSD.
Pharmacologic Pathway - SSRIs and SNRIs
First-line pharmacologic treatments for PTSD include sertraline (Zoloft), paroxetine (Paxil), and venlafaxine (Effexor). These serotonergic and serotonergic-noradrenergic medications are well-documented to induce or worsen RLS in a subset of patients. The mechanism involves serotonergic modulation of dopaminergic transmission. Multiple clinical reports and prospective studies document RLS onset within weeks to months of initiating SSRI or SNRI therapy.
Pharmacologic Pathway - Atypical Antipsychotics
Atypical antipsychotics (risperidone, olanzapine, quetiapine, aripiprazole) are sometimes prescribed as adjunctive therapy for PTSD-related nightmares, hyperarousal, or treatment-resistant symptoms. These agents block dopamine D2 receptors and are recognized causes of RLS and akathisia.
Pharmacologic Pathway - Antihistamines
Diphenhydramine and other antihistamines are commonly used (sometimes prescribed, sometimes self-administered) for PTSD-related insomnia. Antihistamines worsen RLS through central histaminergic and possibly dopaminergic effects.
What 38 CFR 3.310 Requires
Secondary service connection under 38 CFR 3.310 requires three elements.
Service-Connected Primary Condition
PTSD must already be service-connected. The veteran's file should include the rating decision establishing service connection and the current rating.
Current Diagnosis of the Secondary Condition
RLS must be currently diagnosed using IRLSSG criteria by a qualified clinician - typically a primary care physician, neurologist, or sleep medicine specialist. The diagnosis should document each of the five IRLSSG criteria as met.
Medical Nexus Opinion
A medical opinion that the RLS was caused by or aggravated by the service-connected PTSD - directly through shared neurobiology and sleep disruption, or indirectly through PTSD medications. The standard is at least as likely as not (50 percent probability or greater), and the opinion should articulate the specific pathway.
When the nexus theory is aggravation rather than direct causation, 38 CFR 3.310(b) requires the opinion to identify the baseline severity of RLS before aggravation and the current severity following aggravation by the PTSD or its treatment.
How RLS Is Rated by the VA
RLS is not assigned its own diagnostic code in the VA Schedule for Rating Disabilities. Rating boards evaluate RLS by analogy under 38 CFR 4.20 and 4.124a to the most appropriate neurological code.
DC 8520 - Sciatic Nerve
Some rating decisions analogize RLS to incomplete paralysis of the sciatic nerve under DC 8520, with severity tiers of mild (10 percent), moderate (20 percent), moderately severe (40 percent), and severe with marked muscular atrophy (60 percent).
DC 8103 - Convulsive Tics
Other decisions analogize RLS to DC 8103 (convulsive tic), rated at 0, 10, or 30 percent based on the severity and functional impact.
Bilateral Factor
When both lower extremities are affected (the typical pattern), the bilateral factor under 38 CFR 4.26 applies, increasing the combined evaluation by 10 percent of the combined value before further combining with other ratings.
Functional Impact
The rating reflects the functional impact - sleep disruption, daytime fatigue, impact on routine activity, and the degree of relief obtained from treatment. Severe RLS that disrupts sleep nightly and impairs daytime function supports a higher rating.
What the Nexus Letter Should Contain
A defensible nexus letter for RLS secondary to PTSD addresses each legal element and articulates the specific medical reasoning.
Reviewer Credentials
Identify the reviewing clinician (MD, DO, or psychiatric/neurologic NP) and briefly state credentials relevant to neurological and psychiatric diagnosis.
Records Reviewed
Itemized list of records reviewed: service treatment records, VA and private mental health records, the prior rating decision establishing service connection for PTSD, current and historical PTSD medication list, sleep study results if available, and primary care or neurology notes documenting RLS symptoms.
IRLSSG Criteria Documented
Each of the five IRLSSG diagnostic criteria documented as met for this veteran, with specific symptom features cited from the records.
PTSD and Medication History
Summary of PTSD onset, severity, current treatment, and the specific medications prescribed. For each medication implicated in the nexus theory, the documented timeline of initiation, dose escalation, and the temporal relationship to RLS symptom onset.
Nexus Opinion
An explicit at-least-as-likely-as-not opinion that the RLS is caused by or aggravated by the service-connected PTSD or by medications prescribed for service-connected PTSD. When the theory is aggravation, the baseline severity and current severity should be characterized.
Medical Reasoning
Rationale section explaining the specific pathway - shared dopaminergic neurobiology, PTSD-related sleep architecture disruption, serotonergic medication effects, antipsychotic-induced RLS, or antihistamine effects - by which the PTSD is contributing to RLS in this veteran. The rationale should reference the medical literature and the specific clinical features in this veteran's records.
Common Pitfalls
Several recurring issues weaken RLS nexus claims.
Symptom-Only Diagnoses
RLS diagnosed in passing or by self-report carries less weight than RLS diagnosed using the IRLSSG criteria by a qualified clinician. The letter should document each criterion as met.
Wrong Legal Standard
Phrases like "may be related" or "could be related" do not meet the at-least-as-likely-as-not standard. The opinion must use the regulatory language.
Iron Studies Not Addressed
Iron deficiency is a recognized non-PTSD cause of RLS. A strong nexus letter addresses whether iron studies (ferritin, iron, total iron binding capacity, transferrin saturation) have been performed and ruled out iron deficiency as the primary driver - or, when iron deficiency is present, addresses the relative contribution of iron deficiency versus PTSD-related factors.
No Medication Timeline
When the nexus theory rests on PTSD medications, the letter must document the temporal relationship - which medication was started when, at what dose, and when RLS symptoms appeared or worsened.
Related Secondary Conditions to PTSD
PTSD is a frequent primary condition for secondary mental health, sleep, and pharmacologic-side-effect claims.
Insomnia Secondary to PTSD
Chronic insomnia is one of the most reliably documented secondaries to PTSD and is rated under 38 CFR 4.130.
Sleep Apnea Secondary to PTSD
Obstructive sleep apnea has been recognized in multiple Board of Veterans' Appeals decisions as secondary to PTSD through weight gain, medication effects, and sleep architecture disruption.
GERD Secondary to PTSD Medications
GERD developing secondary to NSAIDs or SSRIs prescribed for service-connected conditions is a recognized secondary pathway.
Erectile Dysfunction Secondary to PTSD
Erectile dysfunction secondary to PTSD or SSRI/SNRI treatment is a recognized secondary condition with established pharmacologic and neurobiological mechanisms.
Frequently Asked Questions
Yes. Under 38 CFR 3.310, restless leg syndrome that is caused by or aggravated by service-connected PTSD - or by medications prescribed for service-connected PTSD - can be service-connected on a secondary basis. The veteran must have a current RLS diagnosis using IRLSSG criteria and a medical nexus opinion articulating the specific pathway.
The letter should document each of the five IRLSSG diagnostic criteria, identify the service-connected PTSD and current medication regimen, summarize the temporal relationship between PTSD onset or medication initiation and RLS symptom development, and provide an at-least-as-likely-as-not opinion that the PTSD or its treatment caused or aggravated the RLS. The medical reasoning should reference dopaminergic neurobiology, sleep architecture disruption, or specific medication side effects.
RLS does not have its own diagnostic code. Rating boards evaluate by analogy under 38 CFR 4.20 and 4.124a, typically to DC 8520 (sciatic nerve, with severity tiers from mild at 10 percent to severe at 60 percent) or DC 8103 (convulsive tic, at 0, 10, or 30 percent). The bilateral factor applies when both lower extremities are affected.
A temporal relationship between PTSD medication initiation and RLS onset supports the pharmacologic nexus theory. SSRIs (sertraline, paroxetine), SNRIs (venlafaxine), atypical antipsychotics, and antihistamines are all recognized in the medical literature as causes or exacerbators of RLS. The nexus letter should document the specific medication, the dose, the timing of initiation, and the temporal relationship to symptom onset.
Need a Nexus Letter for RLS Secondary to PTSD?
Semper Solutus provides MD-authored medical opinions and nexus letters linking restless leg syndrome to service-connected PTSD or to medications prescribed for service-connected conditions, under 38 CFR 3.310. Schedule a free consultation to discuss your claim.
Book a Free Consultation